Plasma Proteomic Analysis in Non-Small Cell Lung Cancer Patients Treated with PD-1/PD-L1 Blockade

SIMPLE SUMMARY: Immunotherapy leads to highly variable responses in lung cancer patients. We assessed the value of a blood-based test to predict which patients would benefit from this new treatment modality. We determined that some patients have higher and lower levels of immune markers in their blo...

Descripción completa

Detalles Bibliográficos
Autores principales: Eltahir, Mohamed, Isaksson, Johan, Mattsson, Johanna Sofia Margareta, Kärre, Klas, Botling, Johan, Lord, Martin, Mangsbo, Sara M., Micke, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268315/
https://www.ncbi.nlm.nih.gov/pubmed/34206510
http://dx.doi.org/10.3390/cancers13133116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268315/
https://www.ncbi.nlm.nih.gov/pubmed/34206510
http://dx.doi.org/10.3390/cancers13133116

Ejemplares similares